Insider Transactions in Q1 2024 at Incyte Corp (INCY)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
413
+3.05%
|
$23,128
$56.97 P/Share
|
|
Mar 28
2024
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
403
+2.49%
|
$22,568
$56.97 P/Share
|
|
Mar 28
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,086
+0.01%
|
-
|
|
Mar 25
2024
|
Matteo Trotta EVP, GM, Dermatology US |
BUY
Grant, award, or other acquisition
|
Direct |
7,828
+50.0%
|
-
|
|
Feb 14
2024
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,377
+7.03%
|
-
|
|
Feb 14
2024
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,377
+7.99%
|
-
|
|
Feb 14
2024
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,577
+7.64%
|
-
|
|
Feb 14
2024
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
7,377
+7.98%
|
-
|
|
Feb 14
2024
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
7,377
+12.68%
|
-
|
|
Feb 14
2024
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,377
+7.58%
|
-
|
|
Feb 12
2024
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-0.47%
|
$22,059
$57.84 P/Share
|
|
Jan 22
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.24%
|
$6,588
$61.5 P/Share
|
|
Jan 22
2024
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.15%
|
$6,588
$61.5 P/Share
|
|
Jan 19
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-0.27%
|
$7,442
$61.49 P/Share
|
|
Jan 19
2024
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-0.17%
|
$7,442
$61.49 P/Share
|
|
Jan 18
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
8,114
+15.39%
|
$494,954
$61.18 P/Share
|
|
Jan 18
2024
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
11,359
+13.54%
|
$692,899
$61.18 P/Share
|
|
Jan 17
2024
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,021
-4.36%
|
$62,281
$61.48 P/Share
|
|
Jan 17
2024
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
3,675
-4.52%
|
$224,175
$61.48 P/Share
|
|
Jan 17
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
101
-0.28%
|
$6,161
$61.48 P/Share
|
|
Jan 17
2024
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
101
-0.16%
|
$6,161
$61.48 P/Share
|
|
Jan 16
2024
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
101
-0.28%
|
$6,161
$61.34 P/Share
|
|
Jan 16
2024
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
101
-0.16%
|
$6,161
$61.34 P/Share
|
|
Jan 03
2024
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,365
-7.55%
|
$478,725
$65.51 P/Share
|
|
Jan 02
2024
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
657
-1.49%
|
$42,705
$65.0 P/Share
|